查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球下一代測序(NGS)市場：按產品/服務(消耗品,平台,服務),技術(SBS,納米孔),應用(診斷,藥物發現,農業),用戶(製藥,生技,技術,教育)預測至2027
市場調查報告書
商品編碼
1210258

全球下一代測序(NGS)市場：按產品/服務(消耗品,平台,服務),技術(SBS,納米孔),應用(診斷,藥物發現,農業),用戶(製藥,生技,技術,教育)預測至2027

Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 456 Pages | 訂單完成後即時交付

價格
簡介目錄

全球二代測序 (NGS) 市場規模將從 2022 年的 130 億美元增至 2027 年的 270 億美元，在預測期內(2022-2027 年)以 15.7% 的複合年增長率增長。預計將創歷史新高。 NGS 在癌症研究中的應用增加、癌症發病率增加以及新的 NGS 平台和耗材的推出是預計推動 NGS 市場增長的一些因素。

按產品/服務劃分，耗材部分將在 2021 年佔據最大份額。 因素包括新試劑和試劑盒的推出，以及基因組學研發活動的增加。

從技術來看，SBS(合成測序)將在 2021 年佔據最大份額。

按地區劃分，北美所佔份額最大。 確保研究資金和開發 NGS 數據分析解決方案等因素是市場增長的主要驅動力。

本報告按產品/服務、技術、應用和終端分析了全球下一代測序 (NGS) 市場，包括市場的基本結構和最新發展、主要市場驅動因素和製約因素 我們正在調查按用戶和區域劃分的市場趨勢前景、市場競爭狀況以及主要公司的概況。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 介紹
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 影響客戶業務的趨勢/顛覆
  • 價格分析
  • 技術分析
  • 價值鏈分析
  • 生態系統分析
  • 主要會議和活動 (2023-2024)
  • 波特的五力分析
  • 主要利益相關者和採購標準
  • 專利分析
  • 監管分析

第 6 章下一代測序市場：按產品/服務分類

  • 介紹
  • NGS 耗材
  • 測序服務
    • 外顯子組/靶向重測序，定制 panel
    • RNA測序
    • 從頭測序
    • 芯片測序
    • 全基因組測序
    • 甲基測序
    • 其他測序服務
  • 預排序產品和服務
    • 文庫製備和靶向富集
    • 質量控制
  • NGS平台
  • 生物信息學
    • NGS 數據分析服務
    • NGS 數據分析軟件工作台
    • NGS 存儲、管理和雲計算解決方案
  • NGS 平台服務

第 7 章。下一代測序市場：按技術分類

  • 介紹
  • SBS(合成測序)
  • 離子半導體測序
  • 納米孔測序
  • 單分子實時 (SMRT) 測序
  • 其他測序技術

第 8 章二代測序市場：按應用

  • 介紹
  • 診斷
    • 癌症診斷
    • 傳染病診斷
    • 生殖健康 (RH) 診斷
    • 其他診斷應用
  • 藥物發現和開發
    • 藥物基因組學
    • 其他藥物發現和開發應用
  • 農業和動物研究
  • 其他用途

第 9 章下一代測序市場：最終用戶

  • 介紹
  • 教育機構和研究中心
  • 製藥和生物技術公司
  • 醫院和診所
  • 參考考場
  • 其他最終用戶

第 10 章二代測序市場：按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 荷蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東和非洲
    • 中東
    • 非洲

第11章競爭格局

  • 介紹
  • 大公司採用的權利收購方式
  • 利潤分析
  • 市場份額分析
  • 公司評估矩陣
  • 前 25 家公司的競爭基準
    • 公司範圍內的足跡(所有 25 家公司)
    • 公司產品足跡(所有 25 家公司)
    • 公司的區域足跡(總共 25 家公司)
  • 初創公司/中小企業的業務評估矩陣
  • 初創公司/中小企業的競爭基準
  • 競爭情景和趨勢
    • 產品發布
    • 資本交易
    • 其他趨勢
簡介目錄
Product Code: BT 2697

The global next-generation sequencing market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027. Increasing applications of NGS in cancer research, growing incidence of cancer and launch of new NGS platforms and consumables are some factors projected to drive the growth of the NGS market.

Consumables segment accounted for the largest share of next-generation sequencing market

On the basis of product & service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products & services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R&D activities in genomics.

Sequencing by synthesis segment accounted for the largest share of next-generation sequencing market

Based on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.

The prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).

"North America: Accounted for the largest share in the next-generation sequencing market"

North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side - 20%
  • By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
  • By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%

List of Companies Profiled in the Report:

  • Illumina (US)
  • Thermo Fisher Scientific (US)
  • PerkinElmer (US)
  • BGI Group (China)
  • Agilent Technologies (US)
  • Eurofins Scientific (Luxembourg)
  • Pacific Biosciences (US)
  • Oxford Nanopore Technologies (UK)
  • QIAGEN (Netherlands)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Brooks Automation (US)
  • Psomagen, Inc. (US)
  • 10x Genomics (US)
  • Tecan Group (Switzerland)
  • Zymo Research (US)
  • Takara Bio (Japan)
  • Promega Corporation (US)
  • CD Genomics (US)
  • New England Biolabs (US)
  • Novogene Corporation (China)
  • Hamilton Company (US)
  • MedGenome (US)
  • Becton, Dickinson and Company (US)
  • Genotypic Technology (India)
  • LGC Limited (US)

Research Coverage:

This report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 PRIMARY RESEARCH
    • FIGURE 3 NEXT-GENERATION SEQUENCING MARKET: PRIMARY RESPONDENTS
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 4 NEXT-GENERATION SEQUENCING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
    • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 7 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS, 2022-2027
    • FIGURE 8 NEXT-GENERATION SEQUENCING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
  • 2.4 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 10 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEXT-GENERATION SEQUENCING MARKET

4 PREMIUM INSIGHTS

  • 4.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW
    • FIGURE 15 ADVANCEMENTS IN NGS TECHNOLOGIES TO DRIVE GROWTH
  • 4.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)
    • FIGURE 16 NGS CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
  • 4.3 NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2022 VS. 2027
    • FIGURE 17 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
  • 4.4 NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advancements in NGS platforms
        • 5.2.1.1.1 PromethION 2 Solo
        • 5.2.1.1.2 Ion Torrent Genexus Dx
        • 5.2.1.1.3 iSeq 100 system
        • 5.2.1.1.4 Ion GeneStudio S5
      • 5.2.1.2 Declining cost of genome sequencing
    • FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2021
      • 5.2.1.3 Improving regulatory and reimbursement scenarios for NGS-based diagnostic tests
      • 5.2.1.4 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
    • FIGURE 21 NUMBER OF NEW CANCER CASES WORLDWIDE, 2020
    • TABLE 5 CANCER INCIDENCE, 2020 VS. 2040
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 End-user budget constraints in developing countries
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Application of NGS in precision medicine and molecular diagnostics
      • 5.2.3.2 Government and private support for large-scale sequencing
    • TABLE 6 GLOBAL SEQUENCING INITIATIVES
      • 5.2.3.3 Advancements in NGS data analysis using big data
    • FIGURE 22 DATA PRODUCED DURING HUMAN WHOLE-GENOME SEQUENCING, 2001-2019
      • 5.2.3.4 Development of portable sequencing technologies
      • 5.2.3.5 Partnerships and collaborations for technological advancements in NGS
    • TABLE 7 PARTNERSHIPS AND COLLABORATIONS, JANUARY 2018-DECEMBER 2022
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Interpretation of complex data from NGS platforms
      • 5.2.4.2 Ethical issues
      • 5.2.4.3 Introduction of alternative technologies
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS
  • 5.4 PRICING ANALYSIS
    • TABLE 8 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)
  • 5.5 TECHNOLOGY ANALYSIS
    • TABLE 9 SANGER SEQUENCING VS. NGS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 24 VALUE CHAIN ANALYSIS OF NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
    • FIGURE 25 VALUE CHAIN OF NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW: MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 26 ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET
    • TABLE 10 SUPPLY CHAIN ECOSYSTEM
  • 5.8 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 11 NEXT-GENERATION SEQUENCING MARKET: LIST OF CONFERENCES AND EVENTS
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 12 NEXT-GENERATION SEQUENCING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF SUPPLIERS
    • 5.9.4 BARGAINING POWER OF BUYERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NGS PRODUCTS AND SERVICES
    • FIGURE 28 BUYING CRITERIA FOR NGS PRODUCTS
  • 5.11 PATENT ANALYSIS
    • FIGURE 29 PATENT APPLICATIONS RELATED TO NGS MARKET, JANUARY 2012-DECEMBER 2022
  • 5.12 REGULATORY ANALYSIS
    • 5.12.1 NORTH AMERICA
      • 5.12.1.1 US
    • TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.12.1.2 Canada
    • 5.12.2 EUROPE
    • 5.12.3 ASIA PACIFIC
      • 5.12.3.1 China
    • TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.12.3.2 Japan
      • 5.12.3.3 India
    • 5.12.4 LATIN AMERICA
    • 5.12.5 MIDDLE EAST

6 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 16 NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
  • 6.2 NGS CONSUMABLES
    • 6.2.1 GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL DEMAND FOR NGS CONSUMABLES
    • TABLE 17 NGS CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 18 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 19 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 21 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 22 MIDDLE EAST & AFRICA: NGS CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 SEQUENCING SERVICES
    • TABLE 23 SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 24 SEQUENCING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 25 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 26 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 28 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 29 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
      • 6.3.1.1 Development of technologically advanced NGS products and services to propel growth
    • TABLE 30 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 31 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 32 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 34 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 35 MIDDLE EAST & AFRICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.2 RNA SEQUENCING
      • 6.3.2.1 Launch of RNA sequencing services to drive growth
    • TABLE 36 RNA SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 37 NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 38 EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 40 LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 41 MIDDLE EAST & AFRICA: RNA SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.3 DE NOVO SEQUENCING
      • 6.3.3.1 Rising awareness about advantages of De Novo sequencing to support growth
    • TABLE 42 DE NOVO SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 44 EUROPE: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 46 LATIN AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 47 MIDDLE EAST & AFRICA: DE NOVO SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.4 CHIP SEQUENCING
      • 6.3.4.1 Increasing demand for ChIP sequencing services to propel growth
    • TABLE 48 CHIP SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 49 NORTH AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 50 EUROPE: CHIP SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: CHIP SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 52 LATIN AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 53 MIDDLE EAST & AFRICA: CHIP SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.5 WHOLE-GENOME SEQUENCING
      • 6.3.5.1 Reducing whole-genome sequencing costs to propel growth
    • TABLE 54 WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 55 NORTH AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 56 EUROPE: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 58 LATIN AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 59 MIDDLE EAST & AFRICA: WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.6 METHYL SEQUENCING
      • 6.3.6.1 Rising importance of DNA methylation in study of cancer to drive growth
    • TABLE 60 METHYL SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 61 NORTH AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: METHYL SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: METHYL SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 64 LATIN AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 65 MIDDLE EAST & AFRICA: METHYL SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.7 OTHER SEQUENCING SERVICES
    • TABLE 66 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 67 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 68 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 70 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 71 MIDDLE EAST & AFRICA: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 PRE-SEQUENCING PRODUCTS & SERVICES
    • TABLE 72 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 73 PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 75 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 77 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 78 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.4.1 LIBRARY PREPARATION AND TARGET ENRICHMENT
      • 6.4.1.1 Development of advanced library preparation solutions to boost growth
    • TABLE 79 LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 80 NORTH AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 81 EUROPE: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 83 LATIN AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 MIDDLE EAST & AFRICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.4.2 QUALITY CONTROL
      • 6.4.2.1 Importance of quality control in NGS workflow to drive growth
    • TABLE 85 QUALITY CONTROL MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 86 NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 87 EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 89 LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 90 MIDDLE EAST & AFRICA: QUALITY CONTROL MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.5 NGS PLATFORMS
    • TABLE 91 NGS PLATFORMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 93 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 94 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 96 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 97 MIDDLE EAST & AFRICA: NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.1 ILLUMINA
    • TABLE 98 ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.5.1.1 NovaSeq systems
    • TABLE 100 NOVASEQ SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.5.1.2 NextSeq systems
    • TABLE 101 NEXTSEQ SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.5.1.3 MiSeq systems
    • TABLE 102 MISEQ SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.5.1.4 iSeq 100 systems
    • TABLE 103 ISEQ 100 SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.5.1.5 MiniSeq systems
    • TABLE 104 MINISEQ SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.2 THERMO FISHER SCIENTIFIC
    • TABLE 105 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.3 OXFORD NANOPORE TECHNOLOGIES
    • TABLE 107 OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.4 PACIFIC BIOSCIENCES
    • TABLE 108 PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.5 OTHER NGS PLATFORMS
    • TABLE 109 OTHER NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.6 BIOINFORMATICS
    • TABLE 110 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 111 BIOINFORMATICS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 112 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 115 LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 116 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.6.1 NGS DATA ANALYSIS SERVICES
      • 6.6.1.1 Rising awareness about NGS data analysis services to boost growth
    • TABLE 117 NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 118 NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 119 EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 121 LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 122 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.6.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES
      • 6.6.2.1 Development of advanced bioinformatics solutions to drive growth
    • TABLE 123 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 124 NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 125 EUROPE: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 127 LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 128 MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.6.3 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS
      • 6.6.3.1 Launch of cloud-based solutions to drive market
    • TABLE 129 NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 130 NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 131 EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 133 LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 134 MIDDLE EAST & AFRICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.7 SERVICES FOR NGS PLATFORMS
    • 6.7.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT GROWTH
    • TABLE 135 SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 136 NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 137 EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 139 LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 140 MIDDLE EAST & AFRICA: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020-2027 (USD MILLION)

7 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 141 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
    • TABLE 142 NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
  • 7.2 SEQUENCING BY SYNTHESIS
    • 7.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME PERIOD
    • TABLE 143 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 144 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 145 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 147 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 148 MIDDLE EAST & AFRICA: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 ION SEMICONDUCTOR SEQUENCING
    • 7.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING
    • TABLE 149 ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 150 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 151 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 152 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 153 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 154 MIDDLE EAST & AFRICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 NANOPORE SEQUENCING
    • 7.4.1 NANOPORE SEQUENCING-ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
    • TABLE 155 NANOPORE SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 156 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 157 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 159 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: NANOPORE SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.5 SINGLE-MOLECULE REAL-TIME SEQUENCING
    • 7.5.1 SMRT SEQUENCING PRODUCES RESULTS IN SHORT TIME AND AT LOWER COSTS
    • TABLE 161 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 162 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 163 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 165 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 166 MIDDLE EAST & AFRICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.6 OTHER SEQUENCING TECHNOLOGIES
    • TABLE 167 OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 168 NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 169 EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 171 LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 172 MIDDLE EAST & AFRICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020-2027 (USD MILLION)

8 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 173 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 DIAGNOSTICS
    • TABLE 174 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 175 NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 176 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 177 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 178 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 179 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.1 CANCER DIAGNOSTICS
      • 8.2.1.1 High adoption of NGS in cancer diagnostics to propel growth
    • TABLE 181 NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 186 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.2 INFECTIOUS DISEASE DIAGNOSTICS
      • 8.2.2.1 Applications in infectious disease surveillance and launch of new tests to drive growth
    • TABLE 187 NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 188 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 189 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 190 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 191 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 192 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
      • 8.2.3.1 Extensive use of NGS in NIPT to boost growth
    • TABLE 193 NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 194 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 195 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 196 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 197 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 198 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.4 OTHER DIAGNOSTIC APPLICATIONS
    • TABLE 199 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 200 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 201 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 202 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 203 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 204 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 DRUG DISCOVERY AND DEVELOPMENT
    • TABLE 205 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 206 NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 207 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 208 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 210 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 211 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020-2027 (USD MILLION)
    • 8.3.1 PHARMACOGENOMICS
      • 8.3.1.1 Advent of NGS to understand genomic variants in humans to drive growth
    • TABLE 212 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 213 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 214 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 216 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 217 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020-2027 (USD MILLION)
    • 8.3.2 OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS
    • TABLE 218 NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 219 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 220 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 221 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 222 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 223 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 AGRICULTURAL AND ANIMAL RESEARCH
    • 8.4.1 NGS-BASED ROUTINE SCREENING IN AGRICULTURE TO BOOST MARKET GROWTH
    • TABLE 224 NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 225 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 226 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 227 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 228 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 229 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020-2027 (USD MILLION)
  • 8.5 OTHER APPLICATIONS
    • TABLE 230 NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 231 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 232 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 233 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 234 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 235 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

9 NEXT-GENERATION SEQUENCING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 236 NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS
    • 9.2.1 ACADEMIC AND RESEARCH INSTITUTES TO ACCOUNT FOR LARGEST MARKET SHARE
    • TABLE 237 NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 238 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 239 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 240 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 241 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 242 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.3.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH
    • TABLE 243 NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 244 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 245 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 246 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 247 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 248 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 HOSPITALS AND CLINICS
    • 9.4.1 EXPANDING USE OF NGS IN HOSPITALS AND CLINICS TO BOOST GROWTH
    • TABLE 249 NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 250 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 251 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 252 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 253 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 254 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 REFERENCE LABORATORIES
    • 9.5.1 INCREASING AVAILABILITY OF TESTING SOLUTIONS AND HIGH ADOPTION OF NGS IN REFERENCE LABORATORIES TO DRIVE GROWTH
    • TABLE 255 NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 256 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 257 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 258 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 259 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 260 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020-2027 (USD MILLION)
  • 9.6 OTHER END USERS
    • TABLE 261 NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 262 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 263 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 264 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 265 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 266 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)

10 NEXT-GENERATION SEQUENCING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 267 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
    • TABLE 268 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 269 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 270 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 271 NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 272 NORTH AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 273 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 274 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 275 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 276 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 277 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Growing R&D activities in US to drive market growth
    • TABLE 278 US: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 279 US: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 280 US: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 281 US: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 282 US: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 283 US: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 284 US: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 285 US: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 286 US: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing government initiatives in genomics research to boost adoption of NGS
    • TABLE 287 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 288 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 289 CANADA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 290 CANADA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 291 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 292 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 293 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 294 CANADA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 295 CANADA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 296 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 297 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 298 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 299 EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 300 EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 301 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 302 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 303 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 304 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 305 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominates European next-generation sequencing market
    • TABLE 306 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 307 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 308 GERMANY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 309 GERMANY: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 310 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 311 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 312 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 313 GERMANY: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 314 GERMANY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Strategic initiatives and funding for genomics research to support adoption of NGS
    • TABLE 315 UK: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 316 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 317 UK: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 318 UK: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 319 UK: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 320 UK: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 321 UK: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 322 UK: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 323 UK: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Government initiatives for genomics research to drive growth
    • TABLE 324 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 325 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 326 FRANCE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 327 FRANCE: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 328 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 329 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 330 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 331 FRANCE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 332 FRANCE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Favorable funding scenario to drive adoption of next-generation sequencing
    • TABLE 333 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 334 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 335 ITALY: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 336 ITALY: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 337 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 338 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 339 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 340 ITALY: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 341 ITALY: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Focus on expanding genomic research to support growth
    • TABLE 342 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 343 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 344 SPAIN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 345 SPAIN: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 346 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 347 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 348 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 349 SPAIN: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 350 SPAIN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.6 NETHERLANDS
      • 10.3.6.1 Focus on implementation of NGS to boost growth
    • TABLE 351 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 352 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 353 NETHERLANDS: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 354 NETHERLANDS: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 355 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 356 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 357 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 358 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 359 NETHERLANDS: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 360 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 361 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 362 REST OF EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 363 REST OF EUROPE: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 364 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 365 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 366 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 367 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 368 REST OF EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.8 EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    • FIGURE 31 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET SNAPSHOT
    • TABLE 369 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 370 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 371 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 372 ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 373 ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 374 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 375 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 376 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 377 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 378 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China to register highest growth in Asia Pacific market
    • TABLE 379 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 380 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 381 CHINA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 382 CHINA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 383 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 384 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 385 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 386 CHINA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 387 CHINA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising number of collaborations for NGS to boost market growth
    • TABLE 388 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 389 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 390 JAPAN: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 391 JAPAN: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 392 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 393 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 394 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 395 JAPAN: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 396 JAPAN: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Government initiatives for genomics to support market growth
    • TABLE 397 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 398 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 399 INDIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 400 INDIA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 401 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 402 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 403 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 404 INDIA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 405 INDIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth
    • TABLE 406 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 407 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 408 AUSTRALIA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 409 AUSTRALIA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 410 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 411 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 412 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 413 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 414 AUSTRALIA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 415 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 416 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 417 REST OF ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 418 REST OF ASIA PACIFIC: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 419 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 420 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 421 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 422 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 423 REST OF ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.6 ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    • TABLE 424 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 425 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 426 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 427 LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 428 LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 429 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 430 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 431 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 432 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 433 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Rising focus on clinical genomics to drive demand for NGS
    • TABLE 434 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 435 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 436 BRAZIL: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 437 BRAZIL: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 438 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 439 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 440 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 441 BRAZIL: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 442 BRAZIL: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Biotechnology infrastructure development to support market growth
    • TABLE 443 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 444 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 445 MEXICO: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 446 MEXICO: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 447 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 448 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 449 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 450 MEXICO: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 451 MEXICO: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 452 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 453 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 454 REST OF LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 455 REST OF LATIN AMERICA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 456 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 457 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 458 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 459 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 460 REST OF LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.4 LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • TABLE 461 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 462 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 463 MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 464 MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 465 MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 466 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 467 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 468 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 469 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 470 MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.6.1 MIDDLE EAST
      • 10.6.1.1 Expansion by prominent players and launch of genomic initiatives to support growth
    • TABLE 471 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 472 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 473 MIDDLE EAST: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 474 MIDDLE EAST: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 475 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 476 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 477 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 478 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 479 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.6.2 AFRICA
      • 10.6.2.1 Collaborations among market players and government bodies to boost growth
    • TABLE 480 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 481 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 482 AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 483 AFRICA: BIOINFORMATICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 484 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    • TABLE 485 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 486 AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 487 AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 488 AFRICA: NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 32 NEXT-GENERATION SEQUENCING MARKET: STRATEGIES ADOPTED
  • 11.3 REVENUE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS FOR KEY COMPANIES (2019-2021)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 34 NEXT-GENERATION SEQUENCING MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
    • TABLE 489 NEXT-GENERATION SEQUENCING MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 35 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021
  • 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
    • TABLE 490 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 491 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 492 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
    • FIGURE 36 NEXT-GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
  • 11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
    • TABLE 493 NEXT-GENERATION SEQUENCING MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 494 NEXT-GENERATION SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 495 NEXT-GENERATION SEQUENCING MARKET: KEY PRODUCT LAUNCHES, JANUARY 2019-DECEMBER 2022
    • 11.9.2 DEALS
    • TABLE 496 NEXT-GENERATION SEQUENCING MARKET: KEY DEALS, JANUARY 2019-DECEMBER 2022
    • 11.9.3 OTHER DEVELOPMENTS
    • TABLE 497 NEXT-GENERATION SEQUENCING MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2019-DECEMBER 2022